<DOC>
	<DOCNO>NCT00262002</DOCNO>
	<brief_summary>The purpose study evaluate safety , immunogenicity induction immune memory two three dos Novartis ( Formerly Chiron ) Meningococcal ACWY Conjugate Vaccine administer healthy infant .</brief_summary>
	<brief_title>Study Safety Immune Response Meningococcal Vaccine Administered Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion Criteria Individuals eligible enrollment study male , female infant : Who healthy 2month old infant ( 5589 day , inclusive ) bear full term pregnancy estimate gestational age ≥ 37 week , birth weight ≥ 2.5 kg ; For parent/legal guardian give write informed consent nature study explain ; Who available visit schedule study ; Who good health determine : Medical history ; Physical examination ; Clinical judgment investigator . Exclusion Criteria Ineligible study infant : Whose parents/legal guardian unwilling , unable give write informed consent subject participate study ; Who previously receive meningococcal vaccine ; Who receive prior vaccination D , T , P ( acellular , whole cell ) , IPV , OPV , HBV , H influenzae type b ( Hib ) , Pneumococcus ; Who previously ascertain suspected disease cause N meningitidis , C diphtheriae , C tetani , Poliovirus , Hepatitis B , Hib , Pneumococcus , B pertussis ( history laboratoryconfirmed clinical condition spasmodic cough period ≥ 2 week associate apnea whooping cough ) ; Who household contact and/or intimate exposure individual laboratoryconfirmed N meningitis ( serogroups A , C , W135 , Y ) , B pertussis , Hib , C diphtheriae , Polio , pneumococcal infection since birth ; Who history anaphylactic shock , asthma , urticaria , allergic reaction previous vaccination , know hypersensitivity vaccine component ; Who experience significant acute chronic infection within previous 7 day , fever ( ≥ 38.0°C ) within previous 3 day ; Who present , suspect serious , acute ( e.g. , leukemia , lymphoma ) , chronic disease ( e.g. , sign cardiac , renal failure , severe malnutrition , insulindependent diabetes ) ; progressive neurological disease ; genetic anomaly know cytogenic disorder ( e.g. , Downs syndrome ) ; Who know suspect autoimmune disease impairment /alteration immune function result ( example ) : receipt immunosuppressive therapy since birth ; receipt immunostimulant since birth ; receipt systemic corticosteroid since birth . Who suspect know HIV infection , HIVrelated disease ; Who ever receive blood , blood product and/or plasma derivative , parenteral immunoglobulin preparation ; Who know bleed diathesis , condition may associate prolonged bleeding time ; Who history seizure disorder : Febrile seizure ; Any seizure disorder . Who take systemic antibiotic ( either oral parenteral ) within previous 14 day ( EXCEPTION : subject receive oral parenteral βlactam antibiotic [ example : penicillin , amoxicillin , ceftriaxone , cefuroxime , cephalexin , etc . ] may enrol 7 day follow last dose ) ; Who parents/legal guardian plan leave area study site end study period ; Who condition , opinion investigator , might interfere evaluation study objective ; Who take antipyretic medication previous 6 hour .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>